CBI quizzes 3 ex-senior execs of Anil Ambani group in fraud probe

CBI quizzes 3 ex-senior execs of Anil Ambani group in fraud probe

NEW DELHI: Deepening its investigation into the alleged multi-crore fraud involving Reliance Communications (RCOM) and State Bank of India (SBI), CBI has questioned three former top-tier executives of the Anil Ambani-led Reliance Group.The agency issued summons to Satish Seth and Gautam Doshi, both former group managing directors, for examination in connection with the FIR registered…

Read More
With Anzali attack, Indo-Russian plan of $100billion trade takes a hit

With Anzali attack, Indo-Russian plan of $100billion trade takes a hit

MOSCOW: The US-Israeli missile attack on Iran’s Bandar Anzali, a key transit hub on the INSTC linking Mumbai with St Petersburg, is a major blow to the Indo-Russian ambition of boosting bilateral trade to $100 billion by 2030 via the crucial corridor, experts said Saturday.The 7,200-kilometre long multi-modal International North-South Transport Corridor (INSTC) links Mumbai…

Read More
Securing LPG, LNG, crude oil: India plans evacuation for ships near Strait of Hormuz - here’s what’s being considered

Securing LPG, LNG, crude oil: India plans evacuation for ships near Strait of Hormuz – here’s what’s being considered

India is preparing a contingency plan to evacuate its ships currently stuck in the Persian Gulf. (AI image) Looking to secure crucial energy supplies amidst the Middle East crisis and US-Iran war, India is readying a plan to get ships safely through the Strait of Hormuz. India is preparing a contingency plan to evacuate its…

Read More
Semaglutide Launch: Domestic companies launch semaglutide jabs at affordable prices

Semaglutide Launch: Domestic companies launch semaglutide jabs at affordable prices

NEW DELHI: Several domestic companies including Sun Pharma, Torrent, Zydus, Dr Reddy’s, Glenmark and Alkem announced the launch of semaglutide on Day 1, substantially lowering the cost of weight-loss therapy.This is in the wake of the innovator Novo Nordisk losing its patent on semaglutide on March 20.Sun Pharma’s weekly therapy costs, from initiation to the…

Read More